Lobe Sciences Valuation
| LOBEF Stock | USD 0.02 0.02 882.61% |
Lobe Sciences seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Lobe Sciences from analyzing the firm fundamentals such as Current Valuation of (6.77 M), return on equity of -2.8, and Shares Owned By Insiders of 2.85 % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Lobe Sciences' price fluctuation is out of control at this time. Calculation of the real value of Lobe Sciences is based on 3 months time horizon. Increasing Lobe Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lobe otc stock is determined by what a typical buyer is willing to pay for full or partial control of Lobe Sciences. Since Lobe Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lobe OTC Stock. However, Lobe Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0226 | Real 0.0139 | Hype 0.02 |
The real value of Lobe OTC Stock, also known as its intrinsic value, is the underlying worth of Lobe Sciences OTC Stock, which is reflected in its stock price. It is based on Lobe Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Lobe Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Lobe Sciences helps investors to forecast how Lobe otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lobe Sciences more accurately as focusing exclusively on Lobe Sciences' fundamentals will not take into account other important factors: Lobe Sciences Total Value Analysis
Lobe Sciences is now forecasted to have takeover price of (6.77 M) with market capitalization of 2.01 M, debt of , and cash on hands of 1.38 M. The negative valuation of Lobe Sciences may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Lobe Sciences fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(6.77 M) | 2.01 M | 1.38 M |
Lobe Sciences Asset Utilization
One of the ways to look at asset utilization of Lobe is to check how much profit was generated for every dollar of assets it reports. Lobe Sciences secures a negative usage of assets of -0.65 %, losing $0.006505 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Lobe Sciences shows how discouraging it operates for each dollar spent on its assets.Lobe Sciences Ownership Allocation
Lobe Sciences maintains a total of 76.97 Million outstanding shares. Roughly 97.15 % of Lobe Sciences outstanding shares are held by general public with 2.85 pct. owned by insiders and only 0.0 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Lobe Sciences Profitability Analysis
Net Loss for the year was (12.25 M) with profit before overhead, payroll, taxes, and interest of 841.56 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Lobe Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Lobe Sciences and how it compares across the competition.
About Lobe Sciences Valuation
The otc valuation mechanism determines Lobe Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Lobe Sciences. We calculate exposure to Lobe Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lobe Sciences's related companies.Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences is traded on OTC Exchange in the United States.
8 Steps to conduct Lobe Sciences' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Lobe Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lobe Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Lobe Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Lobe Sciences' revenue streams: Identify Lobe Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Lobe Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Lobe Sciences' growth potential: Evaluate Lobe Sciences' management, business model, and growth potential.
- Determine Lobe Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lobe Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Lobe Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Lobe Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 38.5 M | |
| Retained Earnings | -31 M | |
| Shares Float | 73.8 M |
Complementary Tools for Lobe OTC Stock analysis
When running Lobe Sciences' price analysis, check to measure Lobe Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lobe Sciences is operating at the current time. Most of Lobe Sciences' value examination focuses on studying past and present price action to predict the probability of Lobe Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lobe Sciences' price. Additionally, you may evaluate how the addition of Lobe Sciences to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |